Skip to content
★ Sign in to follow
KN

Kim Nguyen

Executive
Volitionrx Ltd
Total declarations
17
Company
1
▲ Purchases (1 ops.)
€5,299
▼ Sales (0 ops.)
—

Latest filing published 27 Feb 2026 for Volitionrx Ltd.

Filing timeline

BuySale
Kim Nguyen

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 18 May 2021 · 2000 days ago · €5,299
    -28.1%
    Entry US$71.20 · Close at T+365 US$51.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Kim Nguyen: trading record in brief

Kim Nguyen (chief executive) discloses dealings in Volitionrx Ltd to SEC (Form 4). In total, 17 filings cover trades dated from 25 March 2021 to 26 February 2026.

On the market, this insider has only ever bought: 1 purchase, €5,299 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 16 share grants.

Most recently, on 27 February 2026, the filings show a share grant in Volitionrx Ltd. The most recent open-market purchase was published on 18 May 2021, 2,000 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kim Nguyen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    178,000 shares0Common StockSEC:0001477932-26-001098:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    12,000 shares0Common StockSEC:0001477932-26-000359:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    17,424 shares0Common StockSEC:0001477932-25-006096:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    11,983 shares0Common StockSEC:0001477932-25-004374:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    9,893 shares0Common StockSEC:0001477932-25-001464:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    8,648 shares0Common StockSEC:0001477932-24-007802:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    9,171 shares0Common StockSEC:0001477932-24-005493:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    5,000 shares0Common StockSEC:0001477932-24-005034:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    8,011 shares0Common StockSEC:0001477932-24-003482:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    8,500 shares0Common StockSEC:0001477932-24-000411:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    6,750 shares0Common StockSEC:0001477932-23-005114:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    5,625 shares0Common StockSEC:0001477932-23-000270:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    2,625 shares0Common StockSEC:0001477932-22-007690:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    3,046 shares0Common StockSEC:0001477932-22-004665:0
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    1,640 shares0Common StockSEC:0001477932-22-002182:0
  • ▲
    DirectorExecutivesVolitionrx Ltd
    6,400 USD31SEC
    2,000 shares@ US$3.20100.0% of flowCommon StockSEC:0001078782-21-000463:0
    Canonical exit: 12 Aug 2021 (T+90)
  • ◆
    DirectorExecutivesVolitionrx Ltd
    0SEC
    15,000 shares0Common StockSEC:0001078782-21-000283:0

17 of 17 declarations